Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Obstet Gynecol. 2022 Nov 30;141(1):207–214. doi: 10.1097/AOG.0000000000005026

Table 3.

Proportional hazard model after propensity score matching for overall survival.

MULTIVARIABLE
HR (95% CI)
Age in years 1.02 (0.99–1.05) p=0.11

Stage p=0.004*
1b1 1.00
1b2 3.90 (1.76–8.64)
2a1 1.31 (0.18–9.75)

LVSI p=0.045*
No 1.00
Yes 1.98 (1.01–3.91)
unknown 0.82 (0.35–1.92)

Grade p=0.30
1 1.00
2 3.03 (0.68–13.42)
3 2.22 (0.42–11.62)

Adjuvant therapy p=0.67
No 1.00
Yes 1.18 (0.56–2.46)

Diameter p<0.001*
≤ 20 mm 1.00
> 20 mm 2.08 (1.07–4.03)

Surgical Approach p=0.054
Open 1.00
Others 1.88 (0.99–3.57)

Histotype p=0.008*
Squamous 1.00
Adenocarcinoma 1.42 (0.69–2.92)
Other 3.19 (1.35–7.55)

Number of radical hysterectomies per year p=0.27
<7 1.00
7–17 0.43 (0.15–1.21)
>17 0.55 (0.20–1.48)
*

p<0.05